Preclinical evaluation of immunomodulatory effects of aurora kinase inhibition in HPV plus cancers

被引：1
|
作者：
Sinha, Pragya
Ghosh, Soma
Johnson, Faye M.
Sastry, Jagannadha K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5021
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells
    Sandhya Noronha
    Lauren A. C. Alt
    Taylor E. Scimeca
    Omran Zarou
    Justyna Obrzut
    Brian Zanotti
    Elizabeth A. Hayward
    Akhil Pillai
    Shubha Mathur
    Joseph Rojas
    Ribhi Salamah
    Nalini Chandar
    Michael J. Fay
    In Vitro Cellular & Developmental Biology - Animal, 2018, 54 : 71 - 84
  • [42] Preclinical Evaluation of Potential Effects of the Phosphatidylinositol-3-Kinase Inhibitors GDC-0941 and GDC-0980 on Electrocardiogram Parameters
    Morinello, Eric
    Salphati, Laurent
    Ware, Joseph A.
    Wong, Lisa P.
    Kim, Amy H.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2013, 32 (01) : 84 - 84
  • [43] Preclinical evaluation of water-soluble pyrrolo[3,2-d]pyrimidines as single agents with tubulin and multiple receptor tyrosine kinase inhibition and as antitumor agents
    Shah, Khushbu
    Gangjee, Aleem
    Pavana, Roheeth
    Nicholas, Dybdal-Hargreaves F.
    Mooberry, Susuan
    CANCER RESEARCH, 2015, 75
  • [44] Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition
    Seitz, Stephan
    Schally, Andrew V.
    Treszl, Andrea
    Papadia, Andrea
    Rick, Ferenc
    Szalontay, Luca
    Szepeshazi, Karoly
    Ortmann, Olaf
    Halmos, Gabor
    Hohla, Florian
    Buchholz, Stefan
    ANTI-CANCER DRUGS, 2009, 20 (07) : 553 - 558
  • [45] Cooperative anti-tumor effects of combined inhibition of KRASG12C plus autophagy in preclinical models of KRASG12C-driven lung cancer
    Ghazi, Phaedra C.
    Kinsey, Conan
    Bogdan, Madhumita
    Smith, Bryan D.
    Flynn, Daniel L.
    McMahon, Martin
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [46] Cytotoxic Effects of 24-Methylenecyloartanyl Ferulate on A549 Nonsmall Cell Lung Cancer Cells through MYBBP1A Up-Regulation and AKT and Aurora B Kinase Inhibition
    Doello, Sofia
    Liang, Zhibin
    Cho, Il Kyu
    Kim, Jung Bong
    Li, Qing X.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (14) : 3726 - 3733
  • [47] Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1
    Luerman, Gregory C.
    Chuong Nguyen
    Samaroo, Harry
    Loos, Paula
    Xi, Hualin
    Hurtado-Lorenzo, Andres
    Needle, Elie
    Stephen Noell, G.
    Galatsis, Paul
    Dunlop, John
    Geoghegan, Kieran F.
    Hirst, Warren D.
    JOURNAL OF NEUROCHEMISTRY, 2014, 128 (04) : 561 - 576
  • [48] AT9283, A Novel Aurora Kinase/Jak2 Inhibitor Demonstrates Activity against Refractory Infant Leukemia Cells: Studies On Growth Inhibition, Biological Correlates, Drug Synergy and Effects On Leukemia Stem-Like Cells
    Lotfi, Shamim
    Jayanthan, Aarthi
    Lewis, Victor A.
    Guilcher, Greg
    Squires, Matthew S.
    Cooper, Todd
    Narendran, Aru
    BLOOD, 2009, 114 (22) : 1197 - 1197
  • [49] Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d] imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition
    Fan, Chengcheng
    Zhong, Ting
    Yang, Huarong
    Yang, Ying
    Wang, Daoping
    Yang, Xiaosheng
    Xu, Yongnan
    Fan, Yanhua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 190
  • [50] SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naive ALK-, ROS1-, or EGFR-altered Non-small Cell Lung Cancer
    Kano, Hirohisa
    Ichihara, Eiki
    Watanabe, Hiromi
    Nishii, Kazuya
    Ando, Chihiro
    Nakasuka, Takamasa
    Ninomiya, Kiichiro
    Kato, Yuka
    Kubo, Toshio
    Rai, Kammei
    Ohashi, Kadoaki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1653 - 1662
12345